Table 3.
Outcome measure | Overall (n = 7,300) | Women (n = 1,406, 19.3%) | Men (n = 5,894, 80.7%) | P-value |
---|---|---|---|---|
mRS score at 90 days | ||||
0 | 2,470 (43.8) | 382 (33.6) | 2,088 (46.4) | < 0.001 |
1 | 799 (14.2) | 119 (10.5) | 680 (15.1) | |
2 | 541 (9.6) | 104 (9.2) | 437 (9.7) | |
3 | 739 (13.1) | 191 (16.8) | 548 (12.2) | |
4 | 451 (8.0) | 120 (10.6) | 331 (7.4) | |
5 | 328 (5.8) | 105 (9.2) | 223 (5.0) | |
6 | 308 (5.5) | 115 (10.1) | 193 (4.3) | |
mRS category at discharge | ||||
Good (mRS 0–2) | 4,279 (58.6) | 664 (47.2) | 3,615 (61.3) | < 0.001 |
Poor (mRS 3–6) | 3,021 (41.4) | 742 (52.8) | 2,279 (38.7) | |
mRS category at 90 days (n = 5,636, 77.2%) | ||||
Good (mRS 0–2) | 3,810 (67.6) | 605 (53.3) | 3,205 (71.2) | < 0.001 |
Poor (mRS 3–6) | 1,826 (32.4) | 531 (46.7) | 1,295 (28.8) | |
Poor outcome (mRS 3–6) at 90 days (n = 1,826) | ||||
Age < 46 years | 312 (17.1) | 42 (7.9) | 270 (20.8) | < 0.001 |
Age 46–55 years | 382 (20.9) | 45 (8.5) | 337 (26.0) | |
Age 56–65 years | 450 (24.6) | 110 (20.7) | 340 (26.3) | |
Age >65 years | 682 (37.3) | 334 (62.9) | 348 (26.9) | |
Mortality rate at discharge | 144 (2.0) | 38 (2.7) | 106 (1.8) | 0.03 |
Mortality rate at 90 days | 308 (5.5) | 115 (10.1) | 193 (4.3) | < 0.001 |
1-year outcomes | ||||
Recurrent stroke (ischemic or hemorrhagic) | 132 (2.3) | 28 (2.4) | 104 (2.3) | 0.85 |
Post-stroke MI (fatal or non-fatal) | 44 (0.8) | 9 (0.8) | 35 (0.8) | 0.99 |
All-cause mortality | 372 (6.5) | 139 (11.7) | 233 (5.1) | < 0.001 |
Post-stroke cardiac arrest | 94 (1.7) | 37 (3.2) | 57 (1.3) | < 0.001 |
Post-stroke cardiac revascularization (CABG or PCI) | 44 (0.8) | 7 (0.6) | 37 (0.8) | 0.46 |
Major cardiac adverse event (MACE) | 561 (7.7) | 177 (12.6) | 384 (6.5) | < 0.001 |
Total MACEs over 5 years | ||||
0 events | 6,739 (92.3) | 1,229 (87.4) | 5,510 (93.5) | < 0.001 |
1 event | 439 (6.0) | 134 (9.5) | 305 (5.2) | |
2 events | 119 (1.6) | 43 (3.1) | 76 (1.3) | |
3 events | 3 (0.1) | 0 | 3 (0.1) |
mRS, Modified Rankin Scale; MI, myocardial infarction; CABG, coronary artery bypass graft; PCI, percutaneous coronary intervention; MACE, major adverse cardiovascular event.